Matching articles for "neffy"

An Epinephrine Nasal Spray (neffy) for Anaphylaxis

   
The Medical Letter on Drugs and Therapeutics • October 14, 2024;  (Issue 1713)
The FDA has approved an epinephrine nasal spray (neffy – ARS Pharma) for emergency treatment of type 1 hypersensitivity reactions including anaphylaxis in patients who weigh ≥30 kg. It is the first...
The FDA has approved an epinephrine nasal spray (neffy – ARS Pharma) for emergency treatment of type 1 hypersensitivity reactions including anaphylaxis in patients who weigh ≥30 kg. It is the first noninjectable epinephrine product to be approved for this indication.
Med Lett Drugs Ther. 2024 Oct 14;66(1713):163-4 | Show Full IntroductionHide Full Introduction